| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4004191 | American Journal of Ophthalmology | 2009 | 9 Pages |
Abstract
An intravitreal injection of bevacizumab seems to maintain visual acuity. However, CNV frequently recurred or new CNV developed during the long follow-up.
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Miki Sawa, Fumi Gomi, Motokazu Tsujikawa, Hirokazu Sakaguchi, Yasuo Tano,